ZNF510 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.66262999999889E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
7.639000E-03 |
Normal-vs-Stage2 |
2.981900E-02 |
Normal-vs-Stage3 |
1.02389996481378E-09 |
Normal-vs-Stage4 |
1.25449983734427E-10 |
Stage1-vs-Stage2 |
6.165000E-01 |
Stage1-vs-Stage3 |
1.58554999999394E-05 |
Stage1-vs-Stage4 |
5.09990000008287E-07 |
Stage2-vs-Stage3 |
7.492500E-02 |
Stage2-vs-Stage4 |
2.279700E-02 |
Stage3-vs-Stage4 |
3.485800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.76779999996979E-06 |
Normal-vs-AfricanAmerican |
2.46749999999185E-06 |
Normal-vs-Asian |
4.350000E-01 |
Caucasian-vs-AfricanAmerican |
8.685900E-02 |
Caucasian-vs-Asian |
4.457400E-01 |
AfricanAmerican-vs-Asian |
1.677560E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
3.94890000032788E-07 |
Normal-vs-Female |
3.249100E-04 |
Male-vs-Female |
1.752600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.744100E-03 |
Normal-vs-Age(41-60Yrs) |
5.388600E-04 |
Normal-vs-Age(61-80Yrs) |
9.87270000196716E-08 |
Normal-vs-Age(81-100Yrs) |
1.365530E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.217600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.669400E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.661600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.745500E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.106620E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.161200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
8.136800E-01 |
Normal-vs-Grade 2 |
2.111600E-02 |
Normal-vs-Grade 3 |
1.45019996011797E-09 |
Normal-vs-Grade 4 |
6.4733773896819E-12 |
Grade 1-vs-Grade 2 |
2.577000E-01 |
Grade 1-vs-Grade 3 |
1.040260E-03 |
Grade 1-vs-Grade 4 |
2.3007999999991E-05 |
Grade 2-vs-Grade 3 |
1.70219999999777E-05 |
Grade 2-vs-Grade 4 |
4.34460001308423E-09 |
Grade 3-vs-Grade 4 |
3.416500E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.526400E-01 |
Normal-vs-ccB subtype |
2.71029998444305E-09 |
ccA subtype-vs-ccB subtype |
2.01039995761931E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.87849999999856E-05 |
Normal-vs-N1 |
7.88890000000819E-05 |
N0-vs-N1 |
8.676200E-02 |
|
|